by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new
by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new
New possibilities for treating intractable brain tumors unveiledbyThe Korea Advanced Institute of Science and Technology (KAIST)Overview of the study on the enhanced response to anti-PD-1 therap
New possibilities for treating intractable brain tumors unveiledbyThe Korea Advanced Institute of Science and Technology (KAIST)Overview of the study on the enhanced response to anti-PD-1 therap
byUniversity of HelsinkiStrategy of the CGE method to lineage-trace cells with distinct genome editing events using sequence tags with silent or near-silent mutations. a, The CGE method uses a l
byUniversity of HelsinkiStrategy of the CGE method to lineage-trace cells with distinct genome editing events using sequence tags with silent or near-silent mutations. a, The CGE method uses a l
by Monique Mita,Griffith UniversityGriffith School of Applied Psychology Professor Tamara Ownsworth said the Tele-Mast program aims to enhance quality of life for brain tumor survivors. Credit:
by Monique Mita,Griffith UniversityGriffith School of Applied Psychology Professor Tamara Ownsworth said the Tele-Mast program aims to enhance quality of life for brain tumor survivors. Credit:
by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCirculating Hpx is elevated in mice treated with Dox. (A) Dox-induced chronic cardiomyopathy model in mice. i.p., intraperitoneally. (B
by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCirculating Hpx is elevated in mice treated with Dox. (A) Dox-induced chronic cardiomyopathy model in mice. i.p., intraperitoneally. (B
byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall
byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall
(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub
(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub
by Brown UniversityGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101019A new study shows how a drug made from a natural compound used in traditional
by Brown UniversityGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101019A new study shows how a drug made from a natural compound used in traditional
by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy
byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy